Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis

Biomedical Materials
Rajeev Raghavan PillaiKenneth E Gonsalves

Abstract

The goal of this investigation is to develop poly(DL-lactide-co-glycolide) (PLGA) nanoparticles for the delivery of antibiotics such as nafcillin to osteoblasts. This is important in order to treat Staphylococcus aureus-mediated osteomyelitis. The latter is often chronic and highly resistant to antibiotics. Nafcillin (a penicillinase-resistant penicillin)-loaded nanoparticles were prepared by a single emulsion/solvent evaporation method. In vitro drug release studies were conducted in an incubator shaker at 37 degrees C in phosphate buffer saline. Drug loading and release were determined by UV-Vis spectroscopy. A viability study was conducted in S. aureus-infected mouse osteoblasts. In vitro release study showed an initial burst release and a second phase of slow release. Following 24 and 48 h of incubation, all formulations of nanoparticles loaded with nafcillin either killed or significantly reduced all of the intracellular bacteria. Our data demonstrate that effective killing of intracellular S. aureus is possible by treating the infected osteoblasts with nanoparticles loaded with nafcillin.

References

May 1, 1994·Antimicrobial Agents and Chemotherapy·R O Darouiche, R J Hamill
Dec 1, 1995·Microbial Pathogenesis·M C HudsonM T Nousiainen
May 7, 1998·Annals of Biomedical Engineering·C P MarkouS R Hanson
May 27, 1999·Microbial Pathogenesis·J K EllingtonM C Hudson
Jun 24, 1999·Journal of Biomedical Materials Research·L LuA G Mikos
Jul 30, 1999·International Journal of Pharmaceutics·A LamprechtP Maincent
Aug 15, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·N GulyaevaB Zaslavsky
Sep 30, 2000·Journal of Biomaterials Science. Polymer Edition·K W BurtonP P DeLuca
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K S SoppimathW E Rudzinski
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·L MeinelB Gander
Apr 5, 2001·Journal of Biomedical Materials Research·F QianJ Gao
May 23, 2001·Advanced Drug Delivery Reviews·J Siepmann, A Göpferich
Oct 26, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y Zhou, X Y Wu
Dec 3, 2002·Pharmaceutical Research·Tarun K MandalSharlene R Chapman
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Oct 7, 2003·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·M LuckeM Raschke
Jan 24, 2004·Biomaterials·M N V Ravi KumarC M Lehr
Jan 27, 2004·Advanced Drug Delivery Reviews·S Zafar RazzackiMark A Burns
Apr 6, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jagdish JaiswalJorg Kreuter
May 13, 2006·Journal of Biomaterials Science. Polymer Edition·Carlos E Astete, Cristina M Sabliov
Aug 4, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Miechel L T ZweersJan Feijen
Nov 14, 2006·Advanced Drug Delivery Reviews·Davis Yohanes ArifinChi-Hwa Wang

❮ Previous
Next ❯

Citations

Jul 24, 2010·Journal of Materials Science. Materials in Medicine·Teodora ZecheruIzabela-Cristina Stancu
Aug 24, 2012·International Journal of Nanomedicine·Sharif M AbdelghanyChristopher J Scott
Jul 10, 2013·International Journal of Nanomedicine·Wenyi GuYin Xiao
Apr 12, 2014·International Journal of Antimicrobial Agents·Nadia Abed, Patrick Couvreur
Aug 26, 2010·Journal of Orthopaedic Trauma·Theodore MiclauMark E Shirtliff
Jan 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hinojal ZazoJosé M Lanao
Jan 19, 2016·Scientific Reports·Roberto Díez-MartínezPedro García
Feb 23, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabienne DanhierVéronique Préat
Dec 5, 2015·Frontiers in Cellular and Infection Microbiology·Jérôme JosseSophie C Gangloff
Sep 19, 2015·AAPS PharmSciTech·Pedro Henrique Justino Oliveira LimirioPaula Dechichi
Feb 20, 2014·Advanced Drug Delivery Reviews·Meng-Hua XiongJun Wang
Sep 17, 2013·Pharmaceutical Development and Technology·Doaa H MobarakSeham A Elkheshen
May 23, 2015·Journal of Biomaterials Science. Polymer Edition·Yingying CongQing Jiang
Aug 27, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Erica J CarboneKevin W-H Lo
Feb 27, 2010·Journal of the American Chemical Society·Cátia OrnelasMarcus Weck
Jan 2, 2014·Cell Transplantation·Meghan K MurphyKyriacos A Athanasiou
Feb 13, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria Justina Roxana VirlanMaria Greabu
Nov 20, 2015·Journal of Orthopaedic Trauma·Gillian E CookEmil H Schemitsch
Feb 2, 2011·The Journal of Bone and Joint Surgery. British Volume·M El-HusseinyF S Haddad
Mar 17, 2011·The Journal of the American Academy of Orthopaedic Surgeons·Jonathan Agner ForsbergLawrence Webb
Nov 18, 2018·Journal of Interdisciplinary Nanomedicine·Lai JiangChristopher J Scott
Oct 12, 2019·Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih·Zi-Quan WuLei Peng
Sep 11, 2019·Materials Science & Engineering. C, Materials for Biological Applications·Raquel Silva AraújoVanessa Carla Furtado Mosqueira
Sep 1, 2021·Advanced Drug Delivery Reviews·Santhni SubramaniamClive A Prestidge
Dec 16, 2020·Pharmaceutical Nanotechnology·Sweet NaskarKetousetuo Kuotsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.